Variables | Exercise group | Dopamine agonists group | Placebo group |
---|---|---|---|
STS- 5 (sec) | Â | Â | Â |
Baseline | 10.12±2.56 | 8.89±0.74 | 9.69±0.46 |
6-m post | 8.24±2.34†| 8.48±1.72 | 8.81±0.66 |
Δ Change | −1.75±2.32 | - 0.41±1.63 | - 0.88±0.76 |
95% CI of Δ change | −3.03 to −0.47 | −1.91 to 1.09 | −1.58 to −0.18 |
STS-30 (rep) | Â | Â | Â |
Baseline | 14.73±4.00 | 14.83±2.13 | 14.75±0.9 |
6-m post | 17.84± 4.68†| 14.50±2.58 | 17.25±3.2 |
Δ Change | 2.96±4.87 | - 0.33±2.33 | 2.50±2.51 |
95% CI of Δ change | 5.65 to 0.27 | −0.63 to −0.03 | 4.81 to −0.19 |
STS-60 (rep) | Â | Â | Â |
Baseline | 27.95±8.38 | 26.60±3.64 | 30.0±3.16 |
6-m post | 32.50±9.34 | 27.40±7.40 | 32.0±5.35 |
Δ Change | 4.26±8.23 | 0.80±4.65 | 2.00±3.26 |
95% CI of Δ change | 8.77 to −0.25 | 5.09 to −3.49 | 5.0 to −1.0 |
Normal Walk (sec) | Â | Â | Â |
Baseline | 6.09±1.24 | 5.69±1.53 | 5.30±1.06 |
6-m post | 5.81±1.49 | 6.14±1.63 | 5.38±1.09 |
Δ Change | −0.42±1.36 | 0.44±1.46 | 0.07±0.27 |
95% CI of Δ change | −1.17 to 0.33 | 1.78 to −0.90 | 0.31 to −0.17 |
Fast Walk (sec) | Â | Â | Â |
Baseline | 3.86±0.66 | 3.57±0.40 | 3.77±0.47 |
6-m post | 3.65±0.75 | 3.56±0.40 | 3.57±0.41 |
Δ Change | −0.28±0.65 | - 0.01±0.19 | - 0.19±0.40 |
95% CI of Δ change | −0.63 to 0.07 | −0.18 to 0.16 | −0.55 to 0.17 |
NSRI test (sec) | Â | Â | Â |
Baseline | 84.46±21.35 | 70.10±20.46 | 52.48±14.24 |
6-m post | 75.02±26.60†| 67.68±20.78 | 53.44±17.13 |
Δ Change | −9.25±13.41 | −2.41±6.52 | 0.96±4.01 |
95% CI of Δ change | −16.6 to −1.85 | −8.41 to 3.59 | 4.65 to −2.73 |